Vivos Therapeutics (VVOS) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to 0.1.
- Vivos Therapeutics' Equity Ratio fell 8023.08% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 8023.08%. This contributed to the annual value of 0.52 for FY2024, which is 125864.64% up from last year.
- Vivos Therapeutics' Equity Ratio amounted to 0.1 in Q3 2025, which was down 8023.08% from 0.18 recorded in Q2 2025.
- In the past 5 years, Vivos Therapeutics' Equity Ratio registered a high of 0.79 during Q3 2021, and its lowest value of 0.0 during Q3 2023.
- Moreover, its 5-year median value for Equity Ratio was 0.41 (2023), whereas its average is 0.42.
- As far as peak fluctuations go, Vivos Therapeutics' Equity Ratio crashed by 9916.75% in 2023, and later surged by 1110170.84% in 2024.
- Over the past 5 years, Vivos Therapeutics' Equity Ratio (Quarter) stood at 0.76 in 2021, then crashed by 53.84% to 0.35 in 2022, then crashed by 89.05% to 0.04 in 2023, then soared by 1258.65% to 0.52 in 2024, then plummeted by 81.03% to 0.1 in 2025.
- Its Equity Ratio stands at 0.1 for Q3 2025, versus 0.18 for Q2 2025 and 0.39 for Q1 2025.